Shattuck Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Shattuck Labs, Inc. (STTK) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 5.32 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-11
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 674.00K shares.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 4.64M shares, a 93.82% increase year-over-year.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 206.00K shares, a 68.94% decline year-over-year.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 397.80K shares, a 1120.25% increase year-over-year.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 3.00M shares, a 11.02% increase from fiscal 2024.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.70M shares, a 84.71% increase from fiscal 2023.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.46M shares, a 24.56% decline from fiscal 2022.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.94M shares, a 495.29% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 674.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 5.32M shares 10-Q · filed 2026-08-11 | 5.52M shares derived: sum of 3 quarters · filed 2026-08-11 | 5.92M shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 4.64M shares 10-Q · filed 2026-05-07 | 4.85M shares derived: sum of 2 quarters · filed 2026-05-07 | 5.25M shares derived: sum of 3 quarters · filed 2026-05-07 | 5.25M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 206.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 603.80K shares derived: sum of 2 quarters · filed 2026-03-05 | 603.80K shares derived: sum of 3 quarters · filed 2026-03-05 | 3.00M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 397.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 397.80K shares derived: sum of 2 quarters · filed 2025-11-06 | 2.79M shares 10-Q · filed 2025-11-06 | 3.46M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 2.40M shares 10-Q · filed 2025-08-14 | 3.06M shares derived: sum of 3 quarters · filed 2025-08-14 | 3.09M shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 2.40M shares 10-Q · filed 2025-05-01 | 3.06M shares derived: sum of 2 quarters · filed 2025-05-01 | 3.09M shares derived: sum of 3 quarters · filed 2025-05-01 | 3.31M shares derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | 663.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 695.80K shares derived: sum of 2 quarters · filed 2025-03-27 | 917.40K shares derived: sum of 3 quarters · filed 2025-03-27 | 2.70M shares 10-K · filed 2025-03-27 |
| 2024-09-30 | 32.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 254.20K shares derived: sum of 2 quarters · filed 2024-11-14 | 2.04M shares 10-Q · filed 2024-11-14 | 2.04M shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | 221.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 2.01M shares 10-Q · filed 2024-08-01 | 2.01M shares derived: sum of 3 quarters · filed 2024-08-01 | 2.01M shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 1.78M shares 10-Q · filed 2024-05-02 | 1.78M shares derived: sum of 2 quarters · filed 2024-05-02 | 1.79M shares derived: sum of 3 quarters · filed 2024-05-02 | 2.07M shares derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 4.05K shares derived: sum of 2 quarters · filed 2024-02-29 | 281.45K shares derived: sum of 3 quarters · filed 2024-02-29 | 1.46M shares 10-K · filed 2024-02-29 |
| 2023-09-30 | 4.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 281.45K shares derived: sum of 2 quarters · filed 2023-11-09 | 1.46M shares 10-Q · filed 2023-11-09 | 1.62M shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 277.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 1.46M shares 10-Q · filed 2023-08-10 | 1.62M shares derived: sum of 3 quarters · filed 2023-08-10 | 1.86M shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 1.18M shares 10-Q · filed 2023-05-09 | 1.34M shares derived: sum of 2 quarters · filed 2023-05-09 | 1.58M shares derived: sum of 3 quarters · filed 2023-05-09 | 2.04M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 160.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 402.74K shares derived: sum of 2 quarters · filed 2023-02-23 | 860.39K shares derived: sum of 3 quarters · filed 2023-02-23 | 1.94M shares 10-K · filed 2023-02-23 |
| 2022-09-30 | 242.64K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 700.29K shares derived: sum of 2 quarters · filed 2022-11-09 | 1.78M shares 10-Q · filed 2022-11-09 | 1.87M shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 457.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 1.54M shares 10-Q · filed 2022-08-11 | 1.63M shares derived: sum of 3 quarters · filed 2022-08-11 | 1.67M shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 1.08M shares 10-Q · filed 2022-05-12 | 1.17M shares derived: sum of 2 quarters · filed 2022-05-12 | 1.21M shares derived: sum of 3 quarters · filed 2022-05-12 | 1.39M shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 89.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 129.72K shares derived: sum of 2 quarters · filed 2022-03-15 | 314.67K shares derived: sum of 3 quarters · filed 2022-03-15 | 325.67K shares 10-K · filed 2022-03-15 |
| 2021-09-30 | 39.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 224.70K shares derived: sum of 2 quarters · filed 2021-11-09 | 235.70K shares 10-Q · filed 2021-11-09 | 462.80K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 184.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 195.95K shares 10-Q · filed 2021-08-12 | 423.05K shares derived: sum of 3 quarters · filed 2021-08-12 | |
| 2021-03-31 | 11.00K shares 10-Q · filed 2021-05-10 | 238.09K shares derived: sum of 2 quarters · filed 2021-05-10 | ||
| 2020-12-31 | 227.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 1.34M shares 10-K · filed 2021-03-16 | ||
| 2020-09-30 | 1.12M shares 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |